5.10.2007 - 03:00pm ET

(CSRwire) May 10, 2007- Baxter was recently recognized by two organizations, the Ethisphere Council and the U.S. Environmental Protection Agency, for its leadership in ethics, community engagement and environmental initiatives. Additionally, Baxter was applauded for its involvement in local initiatives aimed toward reducing greenhouse gases. Further information about Baxter’s sustainability activities can be found on the Baxter website.

Baxter Recognized as Ethics and Compliance Leader

Baxter has been named to the "World's Most Ethical Companies" list by the Ethisphere Council and Ethisphere magazine for its strong leadership in ethics and compliance, advancement of industry discourse on social and ethical issues, and positive community engagement. The Council chose fewer than 100 companies from several thousand organizations that they analyzed over a six-month period. The process included reviewing companies’ codes of ethics, litigation and regulatory infraction histories; evaluating investment in innovation and sustainable business practices; looking at companies’ activities to improve corporate citizenship; studying nominations from senior executives, industry peers, suppliers and customers; and working with consumer action groups for feedback and rating.

View the Ethisphere website

Baxter Named Green Power Partner by U.S. EPA

Baxter joined the U.S. Environmental Protection Agency’s (EPA’s) Fortune 500 list of Green Power Partners for its significant green power purchase. The EPA recently released its updated Fortune 500 Green Power Partner Challenge list with Baxter’s corporate headquarters campus in Deerfield, Ill. placed at number 22 of 43 companies ranked by green power usage. Baxter purchased Green-e certified renewable energy certificates, equivalent to the 15.5 million kilowatt hours of electricity used on an annual basis at its corporate headquarters campus, from Baltimore-based Constellation NewEnergy, which in turn purchases clean renewable wind energy from a network of wind power generators across the country.

View the complete Fortune 500 Green Power Partners list

View Baxter’s press release

Baxter First Company to Purchase Carbon Credits Offered by Illinois Farmers

Baxter was the first company to purchase carbon credits offered by Illinois farmers and landowners through the Illinois Conservation and Climate Initiative. By voluntarily adopting conservation practices that will reduce greenhouse gases, such as carbon dioxide, nearly 200 farmers and landowners throughout Illinois are earning "carbon credits" that are then sold for payment as offset credits on the Chicago Climate Exchange (CCX). Illinois Environmental Protection Agency Director Doug Scott said he appreciates the support that Baxter, a founding member of the CCX, provides, "As a market-based program, it is important to have solid support from the corporate community, such as Baxter. They are supporting this important environmental endeavor both as a purchaser of carbon credits, but also serve on the Chicago Climate Exchange board."

View the Illinois Conservation and Climate Initiative website

View the Chicago Climate Exchange press release

About Baxter

Baxter's commitment to sustainability spans nearly three decades. The company has been recognized by Innovest Strategic Value Advisors as one of the Global 100 Most Sustainable Corporations in the World and by Corporate Responsibility Officer magazine as one of the 100 Best Corporate Citizens in the United States. Baxter is a member of the Center for Corporate Citizenship at Boston College, the Business Environmental Leadership Council of the Pew Center on Global Climate Exchange, the Chicago Climate Exchange, the U.S. EPA's Climate Leaders, the Ethics & Compliance Officer Association and Hospitals for a Healthy Environment. Baxter endorses the Ceres principles and is an organizational stakeholder of the Global Reporting Initiative. To learn more about Baxter's sustainability initiatives, please visit www.baxter.com/sustainability.

Baxter International Inc. (NYSE:BAX), through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

MEDIA CONTACTS:
Elaine Salewske, (847) 948-3297
Deborah Spak, (847) 948-2349

For more information please contact: